Page 307 - FINAL PROGRAMME 2017

P-709 Effectiveness and safety of follitropin alfa in infertile women using assisted reproductive technology in real-world clinical practice: a multicenter, prospective, open, non-interventional study
P. Sydow1, R. Schneidereit2, K. Pribbernow3, C. Keck4, I. Wiegratz5
1VivaNeo Praxisklinik Sydow Berlin, Private Practice, Berlin, Germany
2Teva GmbH, Medical Affairs- Business Unit Specialty Medicines, Berlin, Germany 3Kinderwunschzentrum Magdeburg, Private Practice, Magdeburg, Germany 4Endokrinologikum Hamburg, Private Practice, Hamburg, Germany
5VivaNeo Kinderwunschzentrum Wiesbaden, Private Practice, Wiesbaden, Germany
P-710 Ovulation induction (OI) or intrauterine insemination (IUI) with gonadotropins in patients with polycystic ovary syndrome (PCOS): description of patients and triggering rates. The GLOBALE- SOPK study
V. Isnard1, P. Sagot2, M. Pasquier3, S. Frantz-Blancpain4, S. Paillet5
1CHU de Nice Hôpital l'Arche II, Nice, France
2ART Department, Dijon Hospital, Dijon, France
3ART Department, Créteil Hospital, Créteil, France
4ART Department, Bordeaux Hospital, Bordeaux, France 5Medical Affairs Department, Merck, Lyon, France
P-711 Effectiveness of a monoclonal antibody against human chorionic gonadotropin (hCG) to prevent reproductive and metabolic dysfunctions in transgenic female mice
C.A. Marcial Lopez1, L. Ratner1, J. Gupta2, K. Nand2, R. Calandra1, G. Talwar2, S. Rulli1 1Instituto de Biología y Medicina Experimental, CONICET, Buenos Aires, Argentina 2Talwar Research Foundation, Talwar Research Foundation, New Delhi, India
P-712 Are there differences in Anti-Müllerian Hormone (AMH) values between populations? Usefulness of AMH reference values in a large Spanish population to predict ovarian reserve
J. Sunol Sala1, M. Junyent1, A. Garcia-Faura1, M.J. Miravitlles1, B. Fernandez-Forner2,
F. Echevarne2, M. Lopez-Teijon1
1Institut Marques, Reproductive Medicine Service, Barcelona, Spain 2Laboratorios Echevarne, Provença- 312- 08037, Barcelona, Spain
P-713 Comparison of pretreatments with leupron stop, oral contraceptive, estrogen priming and estrogen primed antagonist in short antagonist ivf cycles
K. Ulker1, Y. Sahin1, S. Kahraman1
1Istanbul Memorial Hospital, In vitro fertilization and genetic diagnosis, Istanbul, Turkey
FINAL PROGRAMME I GENEVA, SWITZERLAND – 2 TO 5 JULY 2017 307
POSTERS